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Abstract
 
Viral infection and stimulation with lipopolysaccharide (LPS) or double stranded RNA
(dsRNA) induce phosphorylation of interferon (IFN) regulatory factor (IRF)-3 and its translo-
cation to the nucleus, thereby leading to the IFN-
 
 
 
 gene induction. Recently, two I
 
 
 
B kinase
(IKK)–related kinases, inducible I
 
 
 
B kinase (IKK-
 
i
 
) and TANK-binding kinase 1 (TBK1), were
suggested to act as IRF-3 kinases and be involved in IFN-
 
 
 
 production in Toll-like receptor
(TLR) signaling and viral infection. In this work, we investigated the physiological roles of these
kinases by gene targeting. TBK1-deficient embryonic fibroblasts (EFs) showed dramatic decrease
in induction of IFN-
 
 
 
 and IFN-inducible genes in response to LPS or dsRNA as well as after
viral infection. However, dsRNA-induced expression of these genes was residually detected in
TBK1-deficient cells and intact in IKK-
 
i
 
–deficient cells, but completely abolished in IKK-
 
i
 
/
TBK1 doubly deficient cells. IRF-3 activation, in response not only to dsRNA but also to viral
infection, was impaired in TBK1-deficient cells. Together, these results demonstrate that TBK1
as well as, albeit to a lesser extent, IKK-
 
i
 
 play a crucial role in the induction of IFN-
 
 
 
 and IFN-
inducible genes in both TLR-stimulated and virus-infected EFs.
Key words: Toll-like receptor • interferon regulatory factor 3 • NF-
 
 
 
B • 
embryonic ﬁbroblasts • IFN-
 
 
 
Introduction
 
Toll-like receptors (TLRs) are essential for the recognition
of invading pathogens and serve as an important link between
innate and adaptive immunity (1, 2). TLRs can discriminate
various microbial components, such as triacylated lipopeptides
(recognized by TLR1/TLR2 heterodimer), diacylated li-
popeptides (TLR2/TLR6 heterodimer), LPS (recognized
by TLR4), double stranded RNA (dsRNA; recognized
by TLR3), flagellin from bacterial flagella (TLR5), single
stranded RNA (recognized by TLR7/8), and bacterial
DNA containing the unmethylated CpG motif (TLR9;
references 3–12). Recently, it has been also reported that
TLR11 potentially functions to prevent infection of uro-
pathogenic bacteria in mice (13). Intracellular signaling
pathways of TLRs are now being studied extensively (1, 2).
The cytoplasmic region of TLRs contains a Toll/IL-1 re-
ceptor (TIR) domain that is common in both TLR and IL-1
receptor families. The TIR domain triggers TLR signaling
by recruiting a cytoplasmic molecule, MyD88, through the
homophilic interaction of the TIR domains (1, 2). MyD88
also has the death domain that can associate with other
death domain–containing proteins such as IL-1 receptor asso-
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Abbreviations used in this paper:
 
 dsRNA, double stranded RNA; EF, em-
bryonic fibroblast; EMSA, electrophoretic mobility shift assay; ERK, extra-
cellular signal-regulated kinase; IKK, I
 
 
 
B kinase; IKK-
 
i
 
, inducible IKK;
IRF, IFN regulatory factor; ISRE, IFN-stimulated response element; JNK,
c-Jun NH
 
2
 
-terminal kinase; MAP, mitogen-activated protein; poly(I:C),
polyinosine-polycytidylic acid; SeV, Sendai virus; TBK1, TANK-binding
kinase 1; TIR, Toll/IL-1 receptor; TLR, Toll-like receptor; TRAF, TNF
receptor–associated factor; TRIF, TIR domain-containing adaptor inducing
IFN-
 
 
 
; VSV, vesicular stomatitis virus. 
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ciated kinases 1 and 4 (14). This pathway leads to NF-
 
 
 
B
activation through TNF receptor–associated factor (TRAF)
6 and is essential for production of proinflammatory cyto-
kines in response to almost all TLR ligands (15–18).
TLR3 and TLR4 signaling also induce the IFN-
 
 
 
 gene,
which is distinctly regulated from the proinflammatory cy-
tokine genes. Molecular mechanisms for type I IFN (IFN-
 
 
 
/
 
 
 
) induction have been well studied in viral infection
(19–21). Induction of IFN-
 
 
 
 is primarily regulated at tran-
scriptional levels. Previous papers have shown that the IFN-
 
 
 
gene expression is regulated by several transcription fac-
tors, such as NF-
 
 
 
B, ATF-2/c-Jun, IRF-3, and IRF-7.
Gene disruption studies have demonstrated the critical role
of IRF-3 and IRF-7 in the transcription of type I IFN genes
(22, 23). During viral infection, IRF-3 is mainly responsible
for initial activation of the IFN-
 
 
 
 gene (24), whereas IRF-7
expression depends on IFN-
 
 
 
, thereby resulting in robust
induction of type I IFNs in an autocrine positive feedback
manner (21, 25). IRF-3 is located in the cytoplasm in unin-
fected cells. After viral infection, IRF-3 is phosphorylated at
multiple serine/threonine residues located in the COOH-
terminal portion. Phosphorylated IRF-3 forms a homo-
dimer that translocates into the nucleus and activates
promoters containing the IRF-3 binding site, termed IFN-
stimulated response element (ISRE)/IRF-binding element.
IRF-3 activation is also critical for TLR3- and TLR4-
induced up-regulation of the IFN-
 
 
 
 gene. These events are
independent of MyD88, but dependent on another TIR
domain–containing adaptor, TIR domain-containing adap-
tor inducing IFN-
 
 
 
 (TRIF)/TIR-containing adaptor mol-
ecule 1 (26–30). The TRIF-related adaptor molecule is
involved in TLR4- but not TLR3-mediated IFN-
 
 
 
expression (31, 32). Although the molecular mechanism to
induce IRF-3 activation is poorly understood, recent pa-
pers suggested that IRF-3 is phosphorylated by two I
 
 
 
B
kinase (IKK)-related kinases, inducible IKK (IKK-
 
i
 
) and
TANK-binding kinase 1 (TBK1; references 33, 34). IKK-
 
i
 
,
also called IKK-
 
 
 
, was originally identified as an LPS-
inducible kinase (35, 36). TBK1 is also known as NF-
 
 
 
B
activating kinase or TRAF2 associated kinase (37–39). These
two kinases share homology with IKK-
 
 
 
 and IKK-
 
 
 
. Both
kinases have been reported to interact with TRAF2
and the TRAF-binding protein TANK/I-TRAF, and
function upstream of IKK-
 
 
 
 and IKK-
 
 
 
 (37, 40). Defi-
ciency of TBK1 in mice resulted in the embryonic lethality
caused by massive liver degeneration, and TBK1-deficient
(TBK1
 
   
 
) embryonic fibroblasts (EFs) showed reduced
expression of certain genes regulated by NF-
 
 
 
B (39). Thus,
these two IKK-related kinases have been implicated in NF-
 
 
 
B activation. Recently, two groups have shown that IKK-
 
i
 
and TBK1 phosphorylate and activate IRF-3 and IRF-7,
leading to the transcriptional activation of genes for IFN-
 
 
 
,
RANTES, and ISG54 in viral infection as well as in a
TRIF-dependent signaling pathway (32, 33). These in vi-
tro studies suggest that IKK-
 
i
 
 and TBK1 have similar func-
tions; however, it remains unknown how the two kinases
act under physiological conditions.
In this work, we have investigated the physiological roles
of IKK-
 
i
 
 and TBK1 by gene targeting. LPS-induced ex-
pression of IFN-
 
 
 
, but not proinflammatory cytokines, was
markedly reduced in TBK1
 
   
 
 cells. Similar defects were
also observed in poly(I:C)-stimulated and virus-infected
TBK1
 
   
 
 cells. Although IKK-
 
i
 
   
 
 cells showed normal
IFN-
 
 
 
 gene induction, analysis of IKK-
 
i
 
/TBK1 doubly
deficient (IKK-
 
i
 
   
 
TBK1
 
   
 
) cells clearly showed that
IKK-
 
i
 
 is also critically involved in poly(I:C)-induced up-
regulation of IFN-
 
 
 
 and IFN-inducible genes. Poly(I:C)-
induced activation of IRF-3, but not NF-
 
 
 
B, was also im-
paired in IKK-
 
i
 
   
 
TBK1
 
   
 
 cells, indicating that IKK-
 
i
 
 and
TBK1 act through IRF-3 to activate IFN-
 
 
 
. Thus, IKK-
 
i
 
and TBK1 play important roles in IFN-
 
 
 
 gene induction
by LPS, dsRNA, and during viral infection.
 
Materials and Methods
 
Cells, Virus, and Reagents. 
 
Thioglycollate-elicited peritoneal
cells were collected 3 d after intraperitoneal injection of 2 ml of
4% thioglycollate. EFs were prepared from day 11.5–14.5 em-
bryos as described previously (16). Recombinant vesicular stoma-
titis virus (VSV) was a gift from T. Abe and Y. Matsuura (Osaka
University, Osaka, Japan). Sendai virus (SeV) Z strain was pro-
vided by T. Shioda (Osaka University, Osaka, Japan). EFs were
infected with 10
 
9
 
 RNA copies/ml of VSV or multiplicity of in-
fection 10 of SeV. LPS from 
 
Salmonella minnesota
 
 Re-595 was
purchased from Sigma-Aldrich. Synthetic Pam
 
3
 
CSK
 
4
 
 (bacterial li-
popeptide) was obtained from Boehringer. Poly(I:C) was pur-
chased from Amersham Biosciences. Poly(I:C) was complexed
with cationic lipids, Lipofectamin 2000 reagents (Invitrogen), and
added to EFs. TNF-
 
 
 
 and IL-1
 
 
 
 were purchased from Genzyme.
 
Plasmids.
 
To construct the expression vectors for wild-type
IKK-
 
i
 
 and mutant IKK-
 
i
 
 derived from the IKK-
 
i
 
–targeted allele,
IKK-
 
i
 
 cDNA from wild-type and IKK-
 
i
 
   
 
 EFs was sequenced,
cloned, and inserted into pFLAG-CMV2 vector (Sigma-Aldrich).
The human IRF-3 expression vector was constructed by ligation
of human IRF-3 cDNA into pFLAG-CMV2 vector. The ex-
pression vector for human TBK1 was constructed as described
previously (30). The mouse IFN-
 
 
 
 promoter luciferase reporter
was generated by PCR as described previously (30).
 
Generation of IKK-i
 
   
 
 and TBK1
 
   
 
 Mice. 
 
Genomic DNA
fragments encoding IKK-
 
i
 
 and TBK1 were screened from the
129/Sv mice genomic library and characterized by restriction en-
zyme mapping and sequencing analysis. The targeting vectors were
designed by replacing both a 1.0-kbp fragment of the 
 
IKK-i
 
 gene
and a 1.5-kbp fragment of the 
 
TBK1
 
 gene with a neomycin-resis-
tant gene cassette. A herpes simplex virus thymidine kinase gene
driven by MC1 promoter was used for negative selection. The tar-
geting vectors were transfected into E14.1 ES cells. Targeted ES
cells were identified among G418 and ganciclovir doubly resistant
clones by PCR and Southern blotting and subsequently injected
into C57BL/6 blastocysts. Male chimeric mice obtained were
mated with C57BL/6 female mice. The F1 progenies were inter-
crossed to generate homozygotes for each mutated allele.
 
Measurement of IL-6 Production.
 
EFs were stimulated with the
indicated stimulants for 18 h. Concentration of IL-6 in the cul-
ture supernatants were measured by ELISA. The ELISA kit for
IL-6 was purchased from R&D Systems.
 
Northern Blot Analysis. 
 
Total RNA was isolated using Sepa-
zol-RNA I (Nacalai Tesque), electrophoresed, and transferred to 
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nylon membranes. Hybridization was performed with the indicated
cDNA probes as described previously (16). All cDNA probes were
obtained from subtractive screenings as describe previously (16).
 
Electrophoretic Mobility Shift Assay (EMSA). 
 
EFs (10
 
6
 
 cells)
were stimulated with 1.0 
 
 
 
g/ml or 10 
 
 
 
g/ml LPS or 10 
 
 
 
g/ml
poly(I:C) for the indicated periods. Nuclear extracts were pre-
pared and incubated with a radio-labeled oligonucleotide probe
containing NF-
 
 
 
B binding sites or ISRE, and visualized by auto-
radiography as described previously (16).
 
Western Blot Analysis. 
 
To prepare whole cell extracts, LPS-
or poly(I:C)-stimulated cells were lysed in lysis buffer containing
1% Triton X-100, 20 mM Tris-HCl, pH 8.0, 137 mM NaCl,
5 mM EDTA, 10% glycerol, and protease inhibitor cocktail
(Roche Diagnostics). Nuclear extracts were prepared from virus-
infected cells as described previously (16). Whole cell or nuclear
extracts were separated on SDS-PAGE and transferred onto a
polyvinylidene difluoride membrane. The membrane was blotted
with specific antibodies. The membrane-bound Abs were visual-
ized with horseradish peroxidase–conjugated Ab to rabbit IgG
(Amersham Biosciences) using the ECL system (PerkinElmer).
Anti–c-Jun NH
 
2
 
-terminal kinase (JNK) Ab, anti-extracellular sig-
nal-regulated kinase (ERK) Ab, and anti–NF-
 
 
 
B p65 Ab were
obtained from Santa Cruz Biotechnology, Inc. Antibodies against
phospho-JNK and phospho-ERK were purchased from Cell Sig-
naling Technology. Polyclonal anti-IRF-3 antibody was raised as
described previously (28).
 
Native PAGE Assay. 
 
Native PAGE was performed as de-
scribed previously (41). In brief, EFs (106 cells) were stimulated
with 10  g/ml poly(I:C) for the indicated periods, and whole
cell lysates were prepared. Cell lysates in native PAGE buffer
(62.5 mM Tris-HCl, pH 6.8, 15% glycerol) were separated on a
7.5% gel and immunoblotted with anti–IRF-3 Ab.
Reporter Assay.  Human embryonic kidney (HEK) 293 cells
were seeded onto 24-well plates and transiently transfected with
the indicated expression vector together with a reporter plasmid
using Lipofectoamin 2000 reagents. EFs seeded onto six-well
plates were transiently transfected with empty pEF-BOS vector
(MOCK) or pEF-BOS-human TBK1 together with the IFN- 
promoter reporter plasmid using FuGENE 6 transfection reagent
(Roche Diagnostics). 24 h after transfection, the cells were stimu-
lated with 10  g/ml LPS for an additional 12 h. Luciferase activ-
ity of whole cell lysates was measured using a dual-luciferase re-
porter assay system (Promega). The Renilla luciferase reporter
gene (Promega) was used as an internal control.
Microarray Analysis.  Total RNA was extracted from EFs
stimulated with or without LPS for 2 or 4 h and subjected to syn-
Figure 1. Generation of IKK-
i    and TBK1    mice. (A) The
structure of the IKK-i gene, the
targeting vector, and the pre-
dicted mutated allele are shown.
Closed boxes denote the coding
exon. S, SphI. (B) Southern blot
analysis of offspring from the
heterozygote intercrosses. Geno-
mic DNA was extracted from
mouse tails, digested with SphI,
electrophoresed, and hybridized
with the radio-labeled probe in-
dicated in A. Southern blotting
gave a single 19-kbp band for
wild type (   ), a 4-kbp band
for homozygous mutants (   ),
and both bands for heterozygous
mice (   ). (C) Northern blot
analysis of thioglycollate-elicited
peritoneal cells. Thioglycollate-
elicited peritoneal cells from wild
type and IKK-i    mice were
stimulated with 100 ng/ml LPS
for the indicated periods. Total
RNA (10  g) was electro-
phoresed, transferred to a nylon
membrane, and hybridized using
the IKK-i NH2-terminal fragment,
the deleted region of IKK-i gene
in targeting construct, TBK1, or
 -actin cDNA fragment as a
probe. (D) IFN-  promoter re-
porter assay. HEK293 cells were
transiently cotransfected with the
indicated expression vectors and
the IFN-  luciferase reporter vector (0.1  g). 36 h after transfection, luciferase activity in whole cell lysates was measured. (E) The structure of the TBK1
gene, the targeting vector, and the predicted mutated allele are shown. Closed boxes denote the coding exon. B, BamHI. (F) Southern blot analysis of EFs
from the embryos of the heterozygous intercrosses. Genomic DNA was extracted from EFs, digested with BamHI, electrophoresed, and hybridized with
the radiolabeled probe indicated in E. Southern blotting gave a single 3.5-kbp band for wild-type (   ), a 1.2-kbp band for homozygous mutants (   ),
and both bands for heterozygous mice (   ). (G) Northern blot analysis of EFs. Total RNA was extracted from wild-type and TBK1    EFs after stim-
ulation with 1.0  g/ml LPS for the indicated periods, electrophoresed, transferred to a nylon membrane, and hybridized using the IKK-i, TBK1, or
 -actin cDNA fragment as a probe.I B Kinase-related Kinases and IFN-  Induction 1644
thesis of cRNA probe. Preparation of cRNA, hybridization, and
scanning of the microarray were performed according to the
manufacturer’s instructions. A microarray (MG U74A version 2;
Affymetrix, Inc.) was used for the analysis. Data analysis was per-
formed with Microarray Suite software (version 5.0; Affymetrix,
Inc.) and GeneSpring software (Silicon Genetics).
Results
Generation of IKK-i    and TBK1    Mice. To investi-
gate the physiological roles of IKK-i and TBK1, we gener-
ated IKK-i    and TBK1    mice by gene targeting. The
targeting vector used to generate IKK-i /  mice was con-
structed to replace exons 7 and 8 of the murine IKK-i gene
encoding a part of the kinase domain with a neomycin re-
sistant gene cassette (Fig. 1 A). IKK-i    mice were born at
the expected Mendelian frequency, were fertile, and ap-
peared to be healthy (Fig. 1 B). Using an NH2-terminal
fragment of the IKK-i gene as a probe, we detected IKK-i
transcripts in thioglycollate-elicited peritoneal cells from
homozygous mutant mice (Fig. 1 C). However, sequenc-
ing analysis revealed that the IKK-i mRNA from the mu-
tant allele lacked the targeted exons and contained a pre-
mature stop codon, generating a truncated protein that
contained only a part of kinase domains (unpublished data).
Transient transfection assay was used to assess biological ac-
tivity of wild-type and the mutant IKK-i protein (Fig. 1
D). Wild-type IKK-i, but not the mutant, protein induced
activation of the IFN-  promoter in a dose-dependent
manner. In addition, the activity of IRF-3 was enhanced
by coexpression of wild-type, but not mutant IKK-i.
Therefore, we concluded that the mutant IKK-i protein
does not have an activity that can lead to IFN-  induction.
The targeting vector used to generate TBK1    mice
was constructed to replace exon 9 of the murine TBK1
gene with a neomycin-resistant gene cassette (Fig. 1 E).
Mice heterozygous for TBK1 were born and appeared
healthy. However, TBK1    mice died at approximately
embryonic day 14.5 (E14.5) as reported previously (39 and
unpublished data). We obtained fibroblasts from embryos
(EFs) at E12.5 (Fig. 1 F) and examined TBK1 mRNA ex-
pression. In wild-type EFs, TBK1 mRNA was detected
and increased after LPS stimulation. However, in LPS-
stimulated TBK1    EFs, TBK1 mRNA was not detected,
whereas IKK-i gene induction was normal (Fig. 1 G).
IL-6 Production Was Normal in IKK-i    and TBK1   
Cells. IKK-i and TBK1 have been implicated in NF- B
activation (35–40). Because IL-6 production is dependent
Figure 2. Impaired induction of IFN-  and IFN-inducible genes in LPS-stimulated TBK1   , but not IKK-i    EFs. (A) IL-6 production by EFs.
Control (IKK-i    or TBK1   ), IKK-i    (top), or TBK1    (bottom) EFs were stimulated with 10 ng/ml TNF- , 10 ng/ml IL-1 , 100 ng/ml
Pam3CSK4, or 1.0 or 10  g/ml LPS for 24 h. The concentration of IL-6 in the culture supernatants was measured by ELISA. Data are shown as mean  
SD of triplicate samples of one representative experiment from three independent experiments. (B) Gene induction in LPS-stimulated EFs. Control
(IKK-i    or TBK1   ), IKK-i    (left), or TBK1    (right) EFs were stimulated with 1.0  g/ml LPS for the indicated periods. Total RNA was ex-
tracted and subjected to Northern blot analysis for the indicated genes. (C) Microarray analysis of LPS-stimulated EFs. Wild-type and TBK1    EFs were
stimulated with 1.0  g/ml LPS, and RNA was collected at the indicated time points and used to conduct microarray analysis. Absolute expression was
displayed using Genespring software. The color code for absolute signal strength is indicated on the left.Hemmi et al. 1645
on NF- B, we first measured IL-6 production by EFs in
response to various stimuli known to activate NF- B. EFs
were stimulated with TNF , IL-1 , the TLR2 ligand
Pam3CSK4 (triacylated lipopeptides), and the TLR4 ligand
LPS. As shown in Fig. 2 A, IKK-i    and TBK1    EFs
produced similar amounts of IL-6 compared with wild-
type cells in response to all stimulants tested. Moreover,
EMSA analysis showed that NF- B DNA binding activity
was not affected in response to TNF- , IL-1 , or LPS in
both mutant EFs (unpublished data).
Induction of a Set of IFN-inducible Genes in Response to LPS
Was Impaired in TBK1    EFs. LPS stimulates IRF-3 ac-
tivation, which leads to expression of IFN-  and a set
of IFN-inducible genes. Therefore, we first performed
Northern blot analysis to evaluate the expression of LPS-
inducible genes regulated by IRF-3 (Fig. 2 B). Expression
of IFN-  and IFN-inducible genes such as ISG54, IP-10,
IRG1, and RANTES were up-regulated in LPS-stimulated
IKK-i    EFs. These responses were also intact in bone
marrow–derived dendritic cells, and thioglycollate-elicited
peritoneal macrophages of IKK-i    mice (unpublished
data). In contrast, although mRNA induction of RANTES
and IL-6 was similar to that of wild-type EFs, mRNA in-
duction of IFN- , ISG54, IP-10, and IRG1 was severely
impaired in TBK1    EFs.
Next, we performed DNA microarray analysis of LPS-
stimulated EFs. Wild-type and TBK1    EFs were stimu-
lated with LPS for 2 and 4 h. Genes induced in wild-type
EFs are shown in Fig. 2 C. LPS-stimulated expression of
IFN-inducible genes such as Mx2, IRF-7, IFN-inducible
GTPase, and ISG15 were not observed in TBK1   
EFs. In contrast, TBK1    EFs showed normal induction
of MyD88-dependent genes such as IL-6, ICAM-1, and
I B-  (Fig. 2 C).
Next, we examined activation of intracellular signaling
events in LPS-stimulated EFs. EMSA analysis revealed aug-
mentation of NF- B binding activity in both IKK-i    and
TBK1    EFs, comparable to that observed in wild-type
EFs (Fig. 3 A). Alternately, ISRE binding activity was not
augmented in TBK1    EFs, but was observed in both
wild-type and IKK-i    EFs. Next, we examined the acti-
vation of mitogen-activated protein (MAP) kinases. Wild-
type, IKK-i   , and TBK1    cells showed comparable
levels of phosphorylation of JNK and ERK (Fig. 3 B).
To confirm the direct involvement of TBK1 in induc-
tion of IFN- , we investigated whether reconstitution of
TBK1 in TBK1    EFs could restore activation of the
IFN-  promoter upon LPS stimulation (Fig. 3 C). LPS ac-
tivated the IFN-  promoter in mock-transfected wild-type
EFs but not in TBK1    EFs. In contrast, transient expres-
sion of human TBK1 conferred the ability to activate the
IFN-  promoter in LPS-stimulated TBK1    EFs. Thus,
these results demonstrate that TBK1 is essential for induc-
tion of the TLR4-mediated IFN-  expression.
The Response to Poly(I:C) Is Impaired in TBK1    EFs.
Next, we examined the response to the TLR3 ligand,
poly(I:C). Because simple addition of poly(I:C) alone to
the culture did not activate EFs, a poly(I:C) complex with
cationic lipid was first formed and added to the culture to
stimulate the cells, and the expression of IFN-  and IFN-
inducible genes was monitored by Northern blot analysis
(Fig. 4 A). In wild-type EFs, gene induction of IFN- ,
IFN- , ISG54, RANTES, IP-10, and IL-6 was observed
after 2 or 4 h of stimulation. Induction of these genes was
also observed in TLR3-deficient EFs, suggesting that trans-
fection of poly(I:C) to EFs activates these genes in a TLR3-
independent manner. Induction of these genes in IKK-i   
EFs was comparable to that observed in wild-type EFs.
However, in TBK1    cells, induction of the IFN- , IFN- ,
ISGF54, and IRG1 genes was severely reduced. Alter-
nately, mRNA induction of RANTES, IP-10, and IL-6
was not impaired in these cells.
Figure 3. Requirement of TBK1 in LPS-induced ISRE-binding and
activation of the IFN-  promoter. (A) Impaired ISRE-binding in TBK1   
EFs. Control (IKK-i    or TBK1   ), IKK-i   , or TBK1    EFs were
stimulated with 1.0  g/ml LPS for the indicated periods, and ISRE bind-
ing (left) and NF- B binding activity (right) were determined by EMSA.
(B) Activation of MAP kinases in LPS-stimulated EFs. Control (IKK-i   
or TBK1   ), IKK-i   , or TBK1    EFs were stimulated with 10  g/ml
LPS for the times indicated. Whole cell lysates were prepared and blotted
with antiphospho-JNK1/2 Ab (phospho-JNK1/2) or antiphospho-
ERK1/2 Ab (phospho-ERK1/2). The total amounts of JNK1/2 and
ERK1/2 were also determined. One representative experiment is shown.
(C) The expression of TBK1 restored activation of IFN-  promoter in
TBK1    EFs. TBK1    (WT) or TBK1    EFs were cotransfected with
human TBK1 (hTBK1) and the IFN-  promoter luciferase reporter. 24 h
after transfection, the cells were stimulated with or without 10  g/ml LPS
for an additional 12 h before luciferase activity was measured. Similar results
were obtained from two independent experiments.I B Kinase-related Kinases and IFN-  Induction 1646
Next, we evaluated the activation status of the transcrip-
tion factors IRF-3 and NF- B. IRF-3 dimerization was
normally induced in IKK-i    EFs, but dramatically de-
creased in TBK1    EFs (Fig. 4 B). However, both IKK-
i    and TBK1    EFs showed similar NF- B DNA bind-
ing activity to that observed in wild-type cells. (Fig. 4 C).
Moreover, in both IKK-i    and TBK1    EFs, the activa-
tion of MAP kinases including JNK and ERK were nor-
mally induced as compared with wild-type cells (Fig. 4 D).
Thus, the deficiency of TBK1 leads to the impairment of
poly(I:C)-induced IRF-3 activation.
TBK1 Is Essential for Induction of Type I IFNs and IFN-
inducible Genes in Virus-infected EFs. Viral infection also in-
duces phosphorylation and dimerization of IRF-3, leading
to the induction of IFN-  and other antiviral molecules
(42–44). Therefore, next we examined whether virus-
induced gene expression is mediated by IKK-i or TBK1
(Fig. 5 A). EFs were infected with VSV or SeV, and mRNA
expression was examined by Northern blot analysis. In
IKK-i    EFs, induction of mRNA for IFN- , RANTES,
and IP-10 was similar to that of wild-type cells in VSV or
SeV infection. Alternately, in TBK1    cells, the expression
of IFN-  and ISG54 mRNA was not observed, and induc-
tion of IP-10 was markedly diminished compared with
wild-type cells. Although RANTES mRNA induction was
almost normal in VSV infection, the induction was dimin-
ished in SeV infection. To evaluate IRF-3 activation, the
nuclear proteins prepared from VSV-infected wild-type
and TBK1    EFs were immunoblotted to detect IRF-3.
As shown in Fig. 5 B, accumulation of IRF-3 and NF- B
p65 in the nucleus was observed in wild-type cells. The ac-
cumulation of IRF-3 was impaired in TBK1    cells,
whereas NF- B p65 translocation was not affected. These
results indicate that TBK1 is an essential molecule for nu-
clear translocation of IRF-3 that leads to mRNA induction
of IFN-  and other antiviral molecules in viral infection.
IKK-i/TBK1 Doubly Deficient EFs Show That IKK-i Is
Also Involved in Induction of IRF3-regulated Genes. It has
been reported that both IKK-i and TBK1 phosphorylate
Figure 4. Impaired induction of IFN-  and IFN-inducible genes in
poly(I:C)-stimulated TBK1   , but not IKK-i    EFs. (A) mRNA induc-
tion in poly(I:C)-stimulated EFs. Wild-type, TLR3   , IKK-i   , or
TBK1    EFs were transfected with 10  g/ml poly(I:C) for the indicated
period. Total RNA was isolated and subjected to Northern blot analysis
for the indicated genes. (B) Formation of IRF-3 dimer upon poly(I:C)
stimulation. Control (IKK-i    or TBK1   ), IKK-i   , or TBK1    EFs
were transfected with 10  g/ml poly(I:C) and incubated for the indicated
periods. Whole cell extracts were prepared and subjected to native PAGE.
Monomeric and dimeric IRF-3 were detected by Western blotting. (C) NF-
 B DNA binding activity. Wild-type, IKK-i   , or TBK1    EFs were
stimulated with 10  g/ml poly(I:C) for the times indicated, and NF- B
binding was determined by EMSA. (D) MAP kinase activation in poly(I:C)-
stimulated EFs. Control (IKK-i    or TBK1   ), IKK-i   , or TBK1   
EFs were stimulated with 10  g/ml poly(I:C) for the indicated periods.
Whole cell lysates were prepared and blotted with antiphospho-JNK1/2
(phospho-JNK1/2) or antiphospho-ERK1/2 Ab (phospho-ERK1/2).
The total amounts of JNK1/2 and ERK1/2 were also determined. One
representative experiment from two independent experiments is shown.
Figure 5. Requirement of TBK1 for IFN-inducible gene expression in
virus-infected EFs. (A) Control (IKK-i    or TBK1   ), IKK-i   , or
TBK1    EFs were infected with recombinant VSV or SeV for the indi-
cated periods. Total RNA was extracted and subjected to Northern blot
analysis with probes for the indicated genes. Similar results were obtained
from three independent experiments. (B) Nuclear translocation of IRF-3
and NF- B p65 in response to VSV infection. EFs were infected with
recombinant VSV for the indicated periods, and nuclear proteins were
extracted, separated by SDS-PAGE, and blotted with anti-IRF-3 and
NF- B p65 Abs.Hemmi et al. 1647
IRF-3 and IRF-7 in viral infection. Furthermore, as
shown in Fig. 4 A, the induction of IFN-  mRNA, al-
though severely reduced, still remained in poly(I:C)-stimu-
lated TBK1    EFs. These results led us to investigate a
possibility that this residual induction of IFN-  mRNA is
mediated by IKK-i. For this purpose, we established im-
mortalized IKK-i   TBK1    cells and analyzed gene in-
ductions upon poly(I:C) stimulation. In control cells, the
induction of the IFN- , IFN- , ISGF54, IRG1, IP-10,
RANTES, and IL-6 genes was observed with the same ki-
netics as that observed in primary cells (Figs. 4 A and 6 A).
In IKK-i   TBK1    cells, mRNA induction of IFN- ,
IFN- , and ISG54 was completely abolished, and the in-
duction of IRG1 and IP-10 genes was severely impaired
(Fig. 6 A). Moreover, IRF-3 dimerization was abolished
(Fig. 6 B). Meanwhile, RANTES and IL-6 gene expres-
sion was augmented, and activation of NF- B and induc-
tion of JNK and ERK phosphorylation were normally in-
duced in doubly deficient cells (Fig. 6 D). Thus, IKK-i is
also involved in poly(I:C)-induced IFN-  induction and
IRF-3 activation.
Discussion
Activation of TLR3 by dsRNA and of TLR4 by LPS
results in the induction of a set of IFN-induced genes in-
cluding IFN- . These gene inductions are regulated in a
MyD88-independent but TRIF-dependent manner and are
activated by the transcription factor IRF-3 (16, 17, 23, 28,
29). Recent in vitro findings have shown that IKK-i and
TBK1 interact with TRIF and phosphorylate IRF-3 (30,
33, 34). Here, we have examined the physiological role of
these kinases through the generation of knockout mice.
TBK1   , but not IKK-i   , EFs showed a marked decrease
in the induction of the IFN-  and IFN-inducible genes in
response to LPS. In addition, TBK1    fibroblasts showed
impaired response to poly(I:C) as demonstrated by delayed
induction of IFN-  and IFN-inducible genes, and dimin-
ished IRF-3 dimerization. These responses were completely
abolished in IKK-i/TBK1 doubly deficient fibroblasts, dem-
onstrating that IKK-i is also involved in poly(I:C)-induced
IRF-3 activation. However, mRNA induction of IFN- 
and ISG54 was almost completely abolished in LPS-stimu-
lated or virus-infected TBK1    EFs. Alternately, IKK-i   
fibroblasts showed normal levels of gene induction after viral
infection. These results indicate that the involvement of
IKK-i in IRF-3 activation is varied, depending on stimulant.
Further studies should be conducted to clarify the mecha-
nisms of how IKK-i can compensate poly(I:C) stimulation,
but neither LPS stimulation nor virus infection. In addition,
studies using cells other than fibroblasts (e.g., by generating
IKK-i   TBK1    mice under TNF     background) are
required to precisely determine the relative contribution of
IKK-i and TBK1 in the responses in vivo.
IKK-i and TBK1 were originally identified as molecules
that are structurally related to IKK-  and IKK- . Overex-
pression of IKK- , IKK- , IKK-i, or TBK1 leads to NF-
 B activation. However, IKK-i and TBK1 differ from
IKK-  and IKK-  in the way they activate NF- B. IKK- 
and IKK-  phosphorylate both serines 32 and 36 of I- B ,
whereas IKK-i and TBK1 phosphorylate only serine 36
(35–38). Furthermore, previous papers have shown that
IKK-i and TBK1 interact with and phosphorylate TANK/
I-TRAF (37, 40), and the association of TANK with
NEMO–IKK-  and IKK– /  complexes is dramatically
increased in the presence of IKK-i or TBK1 (45), suggest-
ing that IKK-i and TBK1 are involved in NF- B activation
upstream of IKK– / . However, a previous gene paper
revealed that NF- B DNA binding activity is up-regulated
upon either TNF-  or IL-1 stimulation in TBK1    EFs
(39). We have also found that up-regulation of NF- B
DNA binding activity in TBK1    EFs was comparable to
that observed in wild-type cells in response to LPS as well
as TNF-  and IL-1  (unpublished data). A previous work
suggested that TLR4-induced signaling events leading to
activation of NF- B and IRF-3 are diverged at TRIF, and
Figure 6. Involvement of IKK-i in IFN-  gene expression in
poly(I:C) signaling. (A) Impaired mRNA induction in poly(I:C)-stimulated
IKK-i   TBK1    cells. Immortalized control and IKK-i   TBK1   
EFs were transfected with 10  g/ml poly(I:C) and incubated for the indi-
cated period. Total RNA was isolated and subjected to Northern blot
analysis for the indicated genes. The similar results were obtained from
two immortalized EFs. (B) Formation of IRF-3 dimer. Immortalized
control (IKK-i   TBK1   ) and IKK-i   TBK1    EFs were transfected
with 10  g/ml poly(I:C) and incubated for the indicated periods. Whole
cell extracts were prepared and subjected to native PAGE. Monomeric
and dimeric IRF-3 proteins were detected by Western blotting. The sim-
ilar results were obtained from two independently established immortalized
EFs. (C) NF- B DNA binding activity. Immortalized IKK-i   TBK1   
and IKK-i   TBK1    EFs were transfected with 10  g/ml poly(I:C) for
the indicated periods and NF- B binding was determined by EMSA.
Similar results were obtained from two lines of immortalized EFs. *, non-
specific bands. (D) MAP kinase activation. Immortalized IKK-i   TBK1   
and IKK-i   TBK1    EFs were stimulated with 10  g/ml poly(I:C) for
the times indicated. Whole cell lysates were prepared and blotted with
antiphospho-JNK1/2 Ab (phospho-JNK1/2) or antiphospho-ERK1/2
Ab (phospho-ERK1/2). The total amounts of JNK1/2 and ERK1/2
were also determined. One representative experiment from two indepen-
dent experiments is shown.I B Kinase-related Kinases and IFN-  Induction 1648
depend on TRAF6 and TBK1, respectively (30). Thus,
IKK-i and TBK1 are dispensable for NF- B activation, at
least, in response to these stimuli.
TLR3 or TLR4 stimulation of macrophages leads to the
immediate up-regulation of IFN- , IP-10, and RANTES
genes in an IRF-3–dependent manner (46). The present
work shows that induction of IFN-  and IP-10 transcrip-
tion was dramatically decreased in TBK1    EFs infected
with VSV or SeV. However, RANTES mRNA was in-
duced in TBK1    EFs in response to LPS and VSV infec-
tion. Although RANTES mRNA induction appeared to
be slightly diminished in TBK1    EFs compared with
wild-type EFs, the reduction may be due to the lack of sec-
ondary up-regulation by autocrine production of IFN- .
The RANTES gene might be activated by a MyD88-
dependent and IRF3-independent manner as well. These
results indicate that RANTES mRNA expression is regu-
lated differently from that of IFN- , depending on the cell
type or the stimulus applied.
When poly(I:C) is directly introduced to the cytoplasm
of EFs via lipofectamin, IFN-  and IFN-inducible genes
are induced in a TLR3-independent fashion (Fig. 4 A).
This poly(I:C)-induced TLR3-independent cellular activa-
tion is also reported in dendritic cells (47). Interestingly,
poly(I:C)-induced gene expression and activation of IRF-3
were diminished in TBK1    EFs, suggesting that TBK1
also plays an important role in IRF-3 activation in the
TLR3–TRIF-independent signaling pathway. Furthermore,
the analysis of IKK-i   TBK1    EFs revealed that IKK-i
can in part compensate the deficiency of TBK1.
In conclusion, our present studies demonstrate that TBK1
as well as, albeit to a lesser extent, IKK-i are essential for the
activation of IFN-  and IFN-inducible genes in EFs. Con-
trol of these kinases will modulate expression of IFN-  and
IFN-inducible genes without affecting induction of proin-
flammatory cytokines, which should enable us to obtain new
therapeutic treatment for septic shock and viral infection.
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